The first chikungunya vaccine may be on its way with phase 3 trials of a single-shot jab developed by French biotech company Valneva showing the vaccine to be generally safe, well tolerated and provoking an immune response. The study was conducted in the US. Its success will have significant implications for nations like India where chikungunya is endemic.
June 13, 2023 at 12:59AM
from Times of India
https://ift.tt/0PQkGZ1
Phase-3 trials find 1-shot chikungunya vaccine safe: Lancet
Subscribe to:
Post Comments (Atom)
Patriots WR Mack Hollins steals show going shirtless and barefoot in the cold
Patriots receiver Mack Hollins made a memorable entrance for a snow-filled game, arriving shirtless and barefoot despite freezing temperatur...
-
A potential collision was averted at Delhi's IGIA when an Indian carrier's A320, arriving from Phuket, slowed down and failed to pro...
-
An Amarnath Yatra convoy vehicle met with an accident in Udhampur, injuring the driver, while 7,579 pilgrims embarked from Jammu for the hol...
-
Tea bags offer quick, consistent brews with smaller leaf particles, ideal for busy mornings. Loose-leaf tea, featuring whole leaves, provide...
No comments:
Post a Comment